Veterinary Medicine and Surgery Department, Research Support Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA.
Pharmaceutical Sciences Department, Medical Toxicology Research Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA.
Cutan Ocul Toxicol. 2020 Jun;39(2):143-157. doi: 10.1080/15569527.2020.1751183. Epub 2020 Apr 22.
Reactive Skin Decontamination Lotion (RSDL) is an FDA-approved skin decontamination kit carried by service members for removal and neutralisation of vesicants and nerve agents. The RSDL kit, comprised of a lotion-impregnated sponge, was shown to be the superior medical decontamination device for chemical warfare agent (CWA) exposure on intact skin. In the event of a chemical exposure situation (i.e. terrorism, battlefield) physical injuries are probable, and preservation of life will outweigh the risk associated with application of RSDL to compromised skin. The purpose of this study was to quantify the rate and quality of wound healing in epidermal skin wounds treated with RSDL in a porcine model. Degree of wound healing was assessed using bioengineering methods to include ballistometry, colorimetry, evaporimetry, and high-frequency ultrasonography. Clinical observation, histopathology and immunohistochemistry were also utilised. All pigs received four bilateral superficial abdominal wounds via a pneumatic dermatome on their ventral abdomen, then were treated with the following dressings over a seven-day period: RSDL sponge, petroleum based Xeroform gauze, 3 M™ Tegaderm™ Film, and 3 M™ Tegaderm™ Foam. Two additional non-wounded sites on the flank were used as controls. Two groups of pigs were then evaluated for a 21- or 56-day time period, representing short- and long-term wound-healing progression. Our findings indicated RSDL had a negative impact on wound-healing progression at both 21 and 56 days post-injury. Wounds receiving RSDL demonstrated a decreased skin elasticity, significant transepidermal water loss, and altered skin colouration and thickness. In addition, the rate of wound healing was delayed, and return to a functional skin barrier was altered when compared to non-RSDL-treated wounds. In conclusion, wound management care and clinical therapeutic intervention plans should be established to account for a prolonged duration of healing in patients with RSDL-contaminated wounds.
皮肤接触解毒剂(RSDL)是一种经美国食品药品监督管理局(FDA)批准的皮肤解毒套件,由服务人员携带,用于去除和中和水疱剂和神经毒剂。RSDL 套件由浸渍有洗剂的海绵组成,被证明是化学战剂(CWA)暴露于完整皮肤上的优越医疗解毒设备。在发生化学暴露情况(即恐怖主义、战场)时,很可能会造成身体伤害,而挽救生命的重要性将超过将 RSDL 应用于受损皮肤的相关风险。本研究的目的是在猪模型中量化表皮皮肤伤口用 RSDL 治疗的伤口愈合速度和质量。使用生物工程方法评估伤口愈合程度,包括弹道测量、比色法、蒸发法和高频超声检查。还利用了临床观察、组织病理学和免疫组织化学。所有猪的腹部腹侧通过气动表皮刀器都有四个双侧浅层腹部伤口,然后在七天的时间内使用以下敷料进行治疗:RSDL 海绵、石油基 Xeroform 纱布、3M™ Tegaderm™ 膜和 3M™ Tegaderm™ 泡沫。在侧面还有两个额外的非受伤部位作为对照。两组猪分别在 21 天或 56 天的时间内进行评估,代表短期和长期伤口愈合进展。我们的研究结果表明,RSDL 在受伤后 21 天和 56 天都对伤口愈合进展产生了负面影响。使用 RSDL 的伤口显示皮肤弹性降低、显著的经表皮水分丢失以及皮肤颜色和厚度改变。此外,与未用 RSDL 处理的伤口相比,伤口愈合速度延迟,并且恢复功能皮肤屏障的时间也发生了改变。总之,在考虑到 RSDL 污染伤口的愈合时间延长的情况下,应制定伤口管理护理和临床治疗干预计划。